Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Wave Life Sciences is a leading biotechnology company based in Singapore that specializes in the development of innovative RNA medicines. Through its proprietary Stereopure technology, the company addresses rare genetic diseases and provides precise, targeted therapeutic solutions for patients globally.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Wave Life Sciences is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Wave Life Sciences last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at -0.34 USD.
Wave Life Sciences has beaten analyst EPS estimates in 1 of its last 4 evaluated quarters (beat rate: 25%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.